"Dermatan Sulfate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed)
| Descriptor ID |
D003871
|
| MeSH Number(s) |
D09.698.373.200.380
|
| Concept/Terms |
Dermatan Sulfate- Dermatan Sulfate
- Sulfate, Dermatan
- beta-Heparin
- beta Heparin
- Chondroitin Sulfate B
- Sulfate B, Chondroitin
|
Below are MeSH descriptors whose meaning is more general than "Dermatan Sulfate".
Below are MeSH descriptors whose meaning is more specific than "Dermatan Sulfate".
This graph shows the total number of publications written about "Dermatan Sulfate" by people in this website by year, and whether "Dermatan Sulfate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 2 | 1 | 3 |
| 2001 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatan Sulfate" by people in Profiles.
-
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort. Neurology. 2004 Aug 10; 63(3):468-74.
-
Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST). Stroke. 2001 Dec 01; 32(12):2836-40.
-
Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001 May; 32(5):1091-8.
-
Circadian variation in ischemic stroke subtypes. Stroke. 1999 Sep; 30(9):1792-5.
-
Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13; 53(1):122-5.
-
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13; 53(1):126-31.
-
Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Control Clin Trials. 1997 Aug; 18(4):358-77.
-
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 1994 Sep; 25(9):1746-51.
-
Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thromb Haemost. 1992 Mar 02; 67(3):292-6.
-
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis. 1992; 22(2):99-103.